• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗真菌药物研发的最新进展:超越唑类、多烯类和棘白菌素类

Recent Advances in the Development of Antifungal Agents: Beyond Azoles, Polyenes, and Echinocandins.

作者信息

Saini Varsha, Safwan Sayed M, Mehta Devashish, Das Eric Evan, Bajaj Avinash

机构信息

Laboratory of Nanotechnology and Chemical Biology, Regional Centre for Biotechnology, NCR Biotech Cluster, 3rd Milestone Faridabad-Gurgaon Expressway, Faridabad 121001, Haryana, India.

出版信息

ACS Infect Dis. 2025 Jun 13;11(6):1271-1295. doi: 10.1021/acsinfecdis.4c00828. Epub 2025 May 13.

DOI:10.1021/acsinfecdis.4c00828
PMID:40358027
Abstract

The escalating incidence of antimicrobial resistance to antifungal agents, alongside the emergence of drug-resistant fungal strains, constitutes a significant threat to a potential global fungal pandemic. In response, researchers are intensifying efforts to identify novel antifungal compounds through diverse methodologies. Emerging strategies focus on innovative therapeutic targets that may reduce the risk of resistance development while offering broad-spectrum efficacy against fungal infections. Additionally, these approaches present potential cost-effectiveness and accelerated development timelines. This review systematically categorizes a range of novel antifungal compounds, including antifungal peptides, cationic amphiphiles, small molecules, polymers, and repurposed drugs, based on their efficacy in inhibiting fungal growth and associated virulence factors. These compounds exhibit notable antimicrobial activity across in silico, in vitro, and in vivo systems against various pathogenic fungal strains, with several showing substantial promise for clinical application. Furthermore, the review highlights the limitations of standard antifungals and elucidates the mechanisms by which fungal strains develop resistance. This work aims to engage researchers in the distinctive field of fungal biology and foster the exploration of new antifungal strategies.

摘要

抗真菌药物的抗菌耐药性发生率不断上升,同时耐药真菌菌株不断出现,这对潜在的全球真菌大流行构成了重大威胁。作为回应,研究人员正在加大力度,通过各种方法来鉴定新型抗真菌化合物。新兴策略聚焦于创新的治疗靶点,这些靶点可能降低耐药性产生的风险,同时对真菌感染具有广谱疗效。此外,这些方法还具有潜在的成本效益和加速的开发时间表。本综述基于一系列新型抗真菌化合物在抑制真菌生长及相关毒力因子方面的功效,对其进行了系统分类,包括抗真菌肽、阳离子两亲物、小分子、聚合物和重新利用的药物。这些化合物在计算机模拟、体外和体内系统中对各种致病性真菌菌株均表现出显著的抗菌活性,其中有几种在临床应用方面显示出巨大潜力。此外,该综述还强调了标准抗真菌药物的局限性,并阐明了真菌菌株产生耐药性的机制。这项工作旨在让研究人员参与到真菌生物学这一独特领域,并促进对新抗真菌策略的探索。

相似文献

1
Recent Advances in the Development of Antifungal Agents: Beyond Azoles, Polyenes, and Echinocandins.抗真菌药物研发的最新进展:超越唑类、多烯类和棘白菌素类
ACS Infect Dis. 2025 Jun 13;11(6):1271-1295. doi: 10.1021/acsinfecdis.4c00828. Epub 2025 May 13.
2
Elucidating drug resistance in human fungal pathogens.阐明人类真菌病原体的耐药性。
Future Microbiol. 2014;9(4):523-42. doi: 10.2217/fmb.14.18.
3
Sphingolipids as targets for treatment of fungal infections.鞘脂类作为真菌感染治疗的靶点。
Future Med Chem. 2016 Aug;8(12):1469-84. doi: 10.4155/fmc-2016-0053. Epub 2016 Aug 9.
4
Antifungals discovery: an insight into new strategies to combat antifungal resistance.抗真菌药物的发现:对抗真菌耐药性新策略的洞察
Lett Appl Microbiol. 2018 Jan;66(1):2-13. doi: 10.1111/lam.12820. Epub 2017 Dec 11.
5
Antifungals in Clinical Use and the Pipeline.临床应用和研发中的抗真菌药物
Infect Dis Clin North Am. 2021 Jun;35(2):341-371. doi: 10.1016/j.idc.2021.03.005.
6
Recent drug development and treatments for fungal infections.最近的真菌性感染药物研发与治疗进展。
Braz J Microbiol. 2023 Sep;54(3):1695-1716. doi: 10.1007/s42770-023-00999-z. Epub 2023 May 23.
7
[Antifungals for systemic use].[全身用抗真菌药]
Enferm Infecc Microbiol Clin. 2009 Jun;27(6):353-62. doi: 10.1016/j.eimc.2009.04.001. Epub 2009 May 31.
8
The effect of antifungal resistance development on the virulence of Candida species.抗真菌耐药性发展对念珠菌属物种毒力的影响。
FEMS Yeast Res. 2022 Apr 26;22(1). doi: 10.1093/femsyr/foac019.
9
[Clinical relevance of mechanisms of antifungal drug resistance in filamentous fungi].丝状真菌中抗真菌药物耐药机制的临床相关性
Enferm Infecc Microbiol Clin. 2002 Dec;20(10):523-29; quiz 530, 539. doi: 10.1016/s0213-005x(02)72856-5.
10
Fungal sphingolipids: role in the regulation of virulence and potential as targets for future antifungal therapies.真菌鞘脂类:在调节毒力中的作用及其作为未来抗真菌治疗靶点的潜力。
Expert Rev Anti Infect Ther. 2020 Nov;18(11):1083-1092. doi: 10.1080/14787210.2020.1792288. Epub 2020 Jul 16.

引用本文的文献

1
Advancing the Understanding of the Mo-CBP Protein: Unraveling Its Antifungal and Antibiofilm Properties Against Candida Species.深化对Mo-CBP蛋白的理解:揭示其对念珠菌属的抗真菌和抗生物膜特性。
Probiotics Antimicrob Proteins. 2025 Sep 5. doi: 10.1007/s12602-025-10744-7.
2
Synthesis and Antifungal Evaluation Against spp. of 5-Arylfuran-2-Carboxamide Derivatives.5-芳基呋喃-2-甲酰胺衍生物的合成及其对 spp. 的抗真菌活性评价
Microorganisms. 2025 Aug 6;13(8):1835. doi: 10.3390/microorganisms13081835.
3
Overcoming Global Antifungal Challenges: Medical and Agricultural Aspects.
应对全球抗真菌挑战:医学与农业层面
ACS Bio Med Chem Au. 2025 Jul 2;5(4):531-552. doi: 10.1021/acsbiomedchemau.5c00103. eCollection 2025 Aug 20.